Cargando…
Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
BACKGROUND: For the past few years, gene-therapy has recently shown considerable clinical benefit in cancer therapy, and the applications of gene therapies in cancer treatments continue to increase perennially. EZH2, an ideal candidate for tumor gene therapy, plays an important role in the tumorigen...
Autores principales: | Wang, Xiang, Hua, Yuanqi, Xu, Guangya, Deng, Senyi, Yang, Daoke, Gao, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472285/ https://www.ncbi.nlm.nih.gov/pubmed/31043779 http://dx.doi.org/10.2147/IJN.S189871 |
Ejemplares similares
-
Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019) -
Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1
por: Zhou, Peizhi, et al.
Publicado: (2018) -
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013) -
Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)